Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Abstract We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8+ cytotoxic T lymphocytes at first follow-up (the primary endpoint) but detected a significant increase in...

Full description

Bibliographic Details
Main Authors:	Eleni Gkika, Elke Firat, Sonja Adebahr, Erika Graf, Ilinca Popp, Gianluca Radicioni, Simon S. Lo, Ursula Nestle, Nils H. Nicolay, Gabriele Niedermann, Dan G. Duda, Anca-L. Grosu
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-03-01
Series:	npj Precision Oncology
Online Access:	https://doi.org/10.1038/s41698-023-00358-z

Similar Items

Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
by: Eleni Gkika, et al.
Published: (2021-11-01)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
by: Eleni Gkika, et al.
Published: (2017-11-01)

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
by: Eleni Gkika, et al.
Published: (2017-07-01)

FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
by: Montserrat Carles, et al.
Published: (2021-02-01)

Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer
by: Eleni Gkika, et al.
Published: (2020-08-01)

Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With De Novo Lymph Node-Positive Prostate Cancer
by: Simon K.B. Spohn, et al.
Published: (2022-06-01)

Comparison of intraoperative radiotherapy as a boost vs. simultaneously integrated boosts after breast-conserving therapy for breast cancer
by: Raluca Stoian, et al.
Published: (2023-06-01)

The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly
by: Erik Haehl, et al.
Published: (2021-06-01)

Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
by: Eleni Gkika, et al.
Published: (2018-01-01)

Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
by: Eleni Gkika, et al.
Published: (2017-01-01)

Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation
by: Hua Jing, et al.
Published: (2019-02-01)

Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial
by: Simon Kirste, et al.
Published: (2022-10-01)

Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice
by: Kateryna Onyshchenko, et al.
Published: (2023-04-01)

Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients
by: Alexander Rühle, et al.
Published: (2022-09-01)

Surviving Elderly Patients with Head-and-Neck Squamous Cell Carcinoma—What Is the Long-Term Quality of Life after Curative Radiotherapy?
by: Alexander Rühle, et al.
Published: (2021-03-01)

Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma
by: Sati Akbaba, et al.
Published: (2018-08-01)

App-Controlled Treatment Monitoring and Support for Patients With Head and Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled Trial
by: Tanja Sprave, et al.
Published: (2023-10-01)

Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy
by: Alexander Rühle, et al.
Published: (2022-11-01)

Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours
by: Marie Lambrecht, et al.
Published: (2018-10-01)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

Non-invasive in vivo imaging of tumor-associated CD133/prominin.
by: Chizuko Tsurumi, et al.
Published: (2010-12-01)

Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy
by: Jana Schaule, et al.
Published: (2020-06-01)

Non-stereotactic radiotherapy in older cancer patients
by: Silvana Parisi, et al.
Published: (2022-06-01)

Radiotherapy for nonagenarians: the value of biological versus chronological age
by: Tanja Sprave, et al.
Published: (2020-05-01)

Stereotactic body radiotherapy for oligometastases.
by: Tree, A, et al.
Published: (2013)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Stereotactic Radiotherapy for Renal Denervation
by: Mahfoud, Felix, et al.
Published: (2020)

Stereotactic Radiotherapy in Uveal Melanoma
by: Ela Delikgöz Soykut, et al.
Published: (2014-09-01)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy
by: Jana Schaule, et al.
Published: (2020-12-01)

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
by: Andrew B. Barbour, et al.
Published: (2023-07-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

External Validation of the Graded Prognostic Assessment in Patients with Brain Metastases from Small Cell Lung Cancer
by: Carsten Nieder, et al.
Published: (2022-09-01)

Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
by: Simone Gaedicke, et al.
Published: (2023-08-01)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
by: Kylie H. Kang, et al.
Published: (2015-06-01)

Stereotactic body radiotherapy for liver metastases.
by: Aitken, K, et al.
Published: (2015)

Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

Advantages of mini-multileaf in stereotactic radiotherapy
by: Kurup PGG, et al.
Published: (2007-01-01)

Stereotactic Body Radiotherapy for Prostate Cancer
by: Neil R. Parikh M.D., et al.
Published: (2020-06-01)